{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:54:29Z","timestamp":1780368869127,"version":"3.54.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"W1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,2]]},"DOI":"10.1093\/nar\/gky349","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T07:12:52Z","timestamp":1524553972000},"page":"W271-W277","source":"Crossref","is-referenced-by-count":42,"title":["geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4261-9210","authenticated-orcid":false,"given":"Matthias","family":"D\u00f6ring","sequence":"first","affiliation":[{"name":"Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"B\u00fcch","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Friedrich","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Pironti","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhav","family":"Kalaghatgi","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Knops","sequence":"additional","affiliation":[{"name":"Institute of Virology, University of Cologne, F\u00fcrst-P\u00fcckler-Str. 56, 50935 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Heger","sequence":"additional","affiliation":[{"name":"Institute of Virology, University of Cologne, F\u00fcrst-P\u00fcckler-Str. 56, 50935 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Obermeier","sequence":"additional","affiliation":[{"name":"MVZ Medizinisches Infektiologiezentrum Berlin (MIB), Oudenarder Str. 16, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"D\u00e4umer","sequence":"additional","affiliation":[{"name":"Seq-IT, Pfaffpl. 10, 67655 Kaiserslautern, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thielen","sequence":"additional","affiliation":[{"name":"Seq-IT, Pfaffpl. 10, 67655 Kaiserslautern, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Institute of Virology, University of Cologne, F\u00fcrst-P\u00fcckler-Str. 56, 50935 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lengauer","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Pfeifer","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany"},{"name":"Methods in Medical Informatics, Department of Computer Science, University of T\u00fcbingen, Sand 14, 72076 T\u00fcbingen, Germany"},{"name":"Medical Faculty, University of T\u00fcbingen, Geissweg 5, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"key\n\t\t\t\t20180630052759_B1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.antiviral.2006.05.003","article-title":"Algorithms for the interpretation of HIV-1 genotypic drug resistance information","volume":"71","author":"Vercauteren","year":"2006","journal-title":"Antiviral Res."},{"key":"key\n\t\t\t\t20180630052759_B2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000331998","article-title":"The HIVdb system for HIV-1 genotypic resistance interpretation","volume":"55","author":"Tang","year":"2012","journal-title":"Intervirology"},{"key":"key\n\t\t\t\t20180630052759_B3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000331999","article-title":"HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge","volume":"55","author":"Obermeier","year":"2012","journal-title":"Intervirology"},{"key":"key\n\t\t\t\t20180630052759_B4","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1093\/nar\/gkg575","article-title":"Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes","volume":"31","author":"Beerenwinkel","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180630052759_B5","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1097\/QAI.0000000000001198","article-title":"Determination of Phenotypic Resistance Cutoffs From Routine Clinical Data","volume":"74","author":"Pironti","year":"2017","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"key\n\t\t\t\t20180630052759_B6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrmicro1477","article-title":"Bioinformatics-assisted anti-HIV therapy","volume":"4","author":"Lengauer","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"key\n\t\t\t\t20180630052759_B7","doi-asserted-by":"crossref","first-page":"e0174992","DOI":"10.1371\/journal.pone.0174992","article-title":"Using drug exposure for predicting drug resistance \u2013 a data-driven genotypic interpretation tool","volume":"12","author":"Pironti","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180630052759_B8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12859-016-1179-2","article-title":"SHIVA - a web application for drug resistance and tropism testing in HIV","volume":"17","author":"Riemenschneider","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t20180630052759_B9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of Sanger Sequencing, Pyrosequencing,and Melting Curve Analysis for the Detection ofKRASMutations: Diagnostic and Clinical Implications","volume":"12","author":"Tsiatis","year":"2010","journal-title":"J. Mol. Diagn."},{"key":"key\n\t\t\t\t20180630052759_B10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2144\/000113913","article-title":"Improving the limit of detection for Sanger sequencing: A comparison of methodologies for KRAS variant detection","volume":"53","author":"Davidson","year":"2012","journal-title":"Biotechniques"},{"key":"key\n\t\t\t\t20180630052759_B11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1309\/AJCPMWGWGO34EGOD","article-title":"Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing","volume":"141","author":"Lin","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"key\n\t\t\t\t20180630052759_B12","first-page":"1000106","article-title":"Accuracy of Next Generation Sequencing Platforms","volume":"1","author":"Fox","year":"2014","journal-title":"Next Gener. Seq. Appl."},{"key":"key\n\t\t\t\t20180630052759_B13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/v8010012","article-title":"Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing","volume":"8","author":"Vrancken","year":"2016","journal-title":"Viruses"},{"key":"key\n\t\t\t\t20180630052759_B14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing","volume":"70","author":"Cozzi-Lepri","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"key\n\t\t\t\t20180630052759_B15","first-page":"19752","article-title":"Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance","volume":"17","author":"Noguera-Julian","year":"2017","journal-title":"J. Infect. Dis."},{"key":"key\n\t\t\t\t20180630052759_B16","doi-asserted-by":"crossref","first-page":"e0155869","DOI":"10.1371\/journal.pone.0155869","article-title":"Geno2pheno[HCV] \u2013 A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents","volume":"11","author":"Kalaghatgi","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180630052759_B17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/bioinformatics\/btu587","article-title":"VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering","volume":"31","author":"Verbist","year":"2015","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180630052759_B18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2016.11.008","article-title":"MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing","volume":"240","author":"Huber","year":"2017","journal-title":"J. Virol. Methods"},{"key":"key\n\t\t\t\t20180630052759_B19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nbt.2198","article-title":"Performance comparison of benchtop high-throughput sequencing platforms","volume":"30","author":"Loman","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20180630052759_B20","doi-asserted-by":"crossref","first-page":"e49602","DOI":"10.1371\/journal.pone.0049602","article-title":"Use of Four Next-Generation Sequencing Platforms to Determine HIV-1 Coreceptor Tropism","volume":"7","author":"Archer","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180630052759_B21","article-title":"Pre-Existing Low-Levels of the K103N HIV-1 RT Mutation Above a Threshold is Associated with Virological Failure in Treatment-Na\u00efve Patients Undergoing EFV-Containing Antiretroviral Treatment","volume-title":"18th HIV Drug Resistance Workshop","author":"Goodman","year":"2009"},{"key":"key\n\t\t\t\t20180630052759_B22","article-title":"One year of routine HIV-1 drug resistance testing by deep sequencing: insights from comparative Sanger sequencing","volume-title":"12th European HIV & Hepatitis Workshop","author":"Thielen","year":"2014"},{"key":"key\n\t\t\t\t20180630052759_B23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180630052759_B24","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/nar\/13.9.3021","article-title":"Nomenclature for incompletely specified bases in nucleic acid sequences: recommendations 1984","volume":"13","author":"Cornish-Bowden","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180630052759_B25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/313277a0","article-title":"Complete nucleotide sequence of the AIDS virus, HTLV-III","volume":"313","author":"Ratner","year":"1985","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180630052759_B26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","article-title":"Transmission of Hepatitis C by Intrahepatic Inoculation with Transcribed RNA","volume":"277","author":"Kolykhalov","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20180630052759_B27","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1093\/nar\/gkg575","article-title":"Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes","volume":"31","author":"Beerenwinkel","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180630052759_B28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2007.02.003","article-title":"No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: Impact of resistant minority variants on efficacy of low genetic barrier drugs","volume":"39","author":"Van\u00a0Laethem","year":"2007","journal-title":"J. Clin. Virol."},{"key":"key\n\t\t\t\t20180630052759_B29","doi-asserted-by":"crossref","first-page":"e21655","DOI":"10.1371\/journal.pone.0021655","article-title":"Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure","volume":"6","author":"Delobel","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180630052759_B30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment\u2013Naive Patients Significantly Impact Treatment Outcomes","volume":"199","author":"Simen","year":"2009","journal-title":"J. Infect. Dis."},{"key":"key\n\t\t\t\t20180630052759_B31","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment\u2013Na\u00efve Populations and Associate with Reduced Treatment Efficacy","volume":"5","author":"Johnson","year":"2008","journal-title":"PLoS Med."},{"key":"key\n\t\t\t\t20180630052759_B32","doi-asserted-by":"crossref","first-page":"e10952","DOI":"10.1371\/journal.pone.0010952","article-title":"Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Na\u00efve Subjects in the CASTLE Study","volume":"5","author":"Lataillade","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180630052759_B33","doi-asserted-by":"crossref","first-page":"e28952","DOI":"10.1371\/journal.pone.0028952","article-title":"Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection","volume":"6","author":"Stekler","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180630052759_B34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/QAD.0b013e3283034953","article-title":"Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy","volume":"22","author":"Peuchant","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180630052759_B35","doi-asserted-by":"crossref","first-page":"21846","DOI":"10.7448\/IAS.20.1.21846","article-title":"Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000\u20132014","volume":"20","author":"Moscona","year":"2017","journal-title":"J. Int. AIDS Soc."},{"key":"key\n\t\t\t\t20180630052759_B36","doi-asserted-by":"crossref","first-page":"19759","DOI":"10.7448\/IAS.17.4.19759","article-title":"Early clinical response and presence of viral resistant minority variants: a proof of concept study","volume":"17","author":"Callegaro","year":"2014","journal-title":"J. Int. AIDS Soc."},{"key":"key\n\t\t\t\t20180630052759_B37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J. Hepatol."},{"key":"key\n\t\t\t\t20180630052759_B38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/jac\/dkq139","article-title":"Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution","volume":"65","author":"Johnson","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"key\n\t\t\t\t20180630052759_B39","first-page":"556","article-title":"The M184V mutation: what it does, how to prevent it, and what to do with it when it's there","volume":"16","author":"Gallant","year":"2006","journal-title":"AIDS Read."},{"key":"key\n\t\t\t\t20180630052759_B40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.37.4.875","article-title":"Characterization of Human Immunodeficiency Viruses Resistant to Oxathiolane-Cytosine Nucleosides","volume":"37","author":"Schinazi","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180630052759_B41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/430709","article-title":"Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug-Resistant HIV-1 Infection","volume":"41","author":"Campbell","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"key\n\t\t\t\t20180630052759_B42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/01.aids.0000218542.08845.b2","article-title":"Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)","volume":"20","author":"Castagna","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180630052759_B43","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/srep02837","article-title":"Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges","volume":"3","author":"Prosperi","year":"2013","journal-title":"Sci. Rep."},{"key":"key\n\t\t\t\t20180630052759_B44","doi-asserted-by":"crossref","first-page":"e1003515","DOI":"10.1371\/journal.pcbi.1003515","article-title":"Viral Quasispecies Assembly via Maximal Clique Enumeration","volume":"10","author":"T\u00f6pfer","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20180630052759_B45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2016.09.016","article-title":"Recent advances in inferring viral diversity from high-throughput sequencing data","volume":"239","author":"Posada-Cespedes","year":"2017","journal-title":"Virus Res."},{"key":"key\n\t\t\t\t20180630052759_B46","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nbt1371","article-title":"Bioinformatics prediction of HIV coreceptor usage","volume":"25","author":"Lengauer","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20180630052759_B47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12977-016-0320-7","article-title":"A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support","volume":"13","author":"D\u00f6ring","year":"2016","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20180630052759_B48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2006.01.001","article-title":"HBV drug resistance: Mechanisms, detection and interpretation","volume":"44","author":"Shaw","year":"2006","journal-title":"J. Hepatol."},{"key":"key\n\t\t\t\t20180630052759_B49","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1099\/vir.0.043042-0","article-title":"Genotyping hepatitis B virus dual infections using population-based sequence data","volume":"93","author":"Beggel","year":"2012","journal-title":"J. Gen. Virol."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/46\/W1\/W271\/25110528\/gky349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T19:28:53Z","timestamp":1571254133000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/46\/W1\/W271\/4990638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":49,"journal-issue":{"issue":"W1","published-online":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gky349","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,2]]},"published":{"date-parts":[[2018,5,1]]}}}